In Brief: Population Council's levonorgestrel
Population Council's levonorgestrel: Two-rod, 150 mg implant approved Nov. 1 for prevention of pregnancy. The Population Council implant was designated "approvable" May 31. Wyeth-Ayerst's NDA for its two-rod 150 mg levonogestrel implant was cleared Aug. 15; the NDAs were identical except that Wyeth submitted additional educational materials ("The Pink Sheet" Aug. 26, T&G-2)...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth